gdc
MelanomaPreventionSlideshowsWeb Exclusives

Summer Sun Safety Month

August is Summer Sun Safety Month! Did you know that about 80% of UV rays pass through clouds? Dive into our fact-filled slideshow to help you stay safe while having fun in the sun.

Web Exclusives – August 9, 2017

  • Slideshow Summer Safety 1

    August is Summer Sun Safety Month. Dive into our informative slideshow to help keep you safe from the sun!

  • Slideshow Summer Safety 2

    More than 90% of all skin cancers are associated with sun exposure. Avoid sun exposure during peak hours between 10 a.m. and 2 p.m., regardless of the season. For best results, sunscreens must be reapplied at least every 2 hours.

    (Source: Skin Cancer Foundation)
  • Slideshow Summer Safety 3

    Be sure to use a broad-spectrum (or full-spectrum) sunscreen—the only type of sunscreen that provides protection against both UVB and UVA rays. UVB rays usually burn the superficial layers of the skin, while UVA rays can prematurely age your skin by causing wrinkling and age spots.

    (Source: American Cancer Society)
  • Slideshow Summer Safety 4

    UV rays can easily go through a white cotton T-shirt, especially if it’s wet. Most wet, light-colored t-shirts only give as much protection as an SPF 4 sunscreen—well below the minimum of SPF 30 recommended by the American Cancer Society.

    (Source: American Cancer Society)
  • Slideshow Summer Safety 5

    Water-resistant sunscreens are made to protect your skin from burning when you swim or sweat, but usually only last for 40 minutes. “Very” water-resistant sunscreens last up to 80 minutes.

    (Source: Mayo Clinic)
  • Slideshow Summer Safety 6

    Remember, UV rays penetrate clouds, so use sunscreen even when it’s cloudy! About 80% of UV rays pass through clouds.
    (Source: Skin Cancer Foundation)

  • Slideshow Summer Safety 7

    Want to learn more about skin cancer? Click here to check out our articles on this topic.

Recommended For You
LeukemiaNewsworthyWeb Exclusives
Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation
This is the first treatment that targets patients with AML and the FLT3-ITD mutation. In this clinical trial, patients who received quizartinib lived longer without disease progression than those receiving chemotherapy.
MelanomaSlideshowsWeb Exclusives
Skin Cancer Awareness Month
May is Skin Cancer Awareness Month! View this slideshow to learn the latest statistics in the United States, leading causes and preventive measures, and quick facts on melanoma, one of the most common types of skin cancer. Conquer cancer with knowledge.
Breast CancerNewsworthyWeb Exclusives
Breaking News: Sellas Announces Promising Data on NeuVax in Combination with Herceptin in HER2 1+/2+ Breast Cancer
NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.
SlideshowsWeb Exclusives
Testicular Cancer Awareness Month
April is Testicular Cancer Awareness Month! Take a cruise through this slideshow full of facts about testicular cancer, such as the common risk factors and symptoms to look out for. Conquer cancer with knowledge.
Last modified: October 5, 2017

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country